GLP-1 receptor agonists, a diabetic medication may help in reducing alcohol consumption and alcohol-related health problems.

TUESDAY, Nov. 5, 2024 -- In a multisociety clinical practice guidance document, published online Oct. 29 in Surgery for Obesity and Related Diseases,...

New research, led by experts at the University of Nottingham, has found that certain types of medication used to treat diabetes may be effective in...

A recent study has shown that the weight-loss drug Ozempic, along with other medications in its class, may significantly lower the risk of heart...

Glucagon-like peptide-1-receptor agonists (GLP-1RA) are medications that are increasingly prescribed for patients with type 2 diabetes and congestive...

TUESDAY, Nov. 12, 2024 -- For patients with ischemic stroke, sodium-glucose cotransporter-2 inhibitors (SGLT-2is) and glucagon-like peptide-1 receptor...

TUESDAY, Nov. 12, 2024 -- For patients with ischemic stroke, sodium-glucose cotransporter-2 inhibitors (SGLT-2is) and glucagon-like peptide-1 receptor...

THURSDAY, Nov. 7, 2024 -- Expanding access to obesity medications such as glucagon-like peptide 1 (GLP-1) receptor agonists and dual gastric...

THURSDAY, Nov. 14, 2024 -- For patients with type 2 diabetes mellitus (T2DM), glucagon-like peptide 1 receptor agonist (GLP-1 RA) use is associated...

The rise in type 2 diabetes has become a significant public health concern in recent years. This form of diabetes happens when the body struggles to...